期刊
HUMAN PATHOLOGY
卷 44, 期 9, 页码 1918-1926出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.humpath.2013.03.001
关键词
Local recurrence; Metastasis; Soft tissue sarcoma; Tissue microarray
类别
资金
- National Institutes of Health Pediatric Cancer Epidemiology Training Grant [T32 CA099936]
- Children's Cancer Research Fund, Minneapolis, MN
- Karen Wyckoff Rein in Sarcoma Foundation
Although rare, synovial sarcoma (SS) is one of the most common soft tissue sarcomas affecting young adults. To investigate potential tumor markers related to synovial sarcoma prognosis, we carried out a single-institution retrospective analysis of 103 patients diagnosed with SS between 1980 and 2009. Clinical outcome data were obtained from medical records, and archived tissue samples were used to evaluate the relationship between progression-free survival (PFS) and several prognostic factors, including tumor expression of FGFR3 and FGFR4. No associations were found between PFS and gender, body mass index, tumor site, SS18-SSX translocation, or FGFR4 expression. As seen in previous studies, age at diagnosis (<35, 63% versus >= 35 years, 31% 10-year PFS; P=.033), histologic subtype (biphasic, 75% versus monophasic 34% 10-year PFS; P=.034), and tumor size (<= 5 cm, 70% versus >5 cm, 22% 10-year PFS; P<.0001) were associated with PFS in SS patients. In addition, in a subset of patients with available archived tumor samples taken prior to chemotherapy or radiation (n = 34), higher FGFR3 expression was associated with improved PFS (P=.030). To the best of our knowledge, this is the largest study of SS to date to suggest a potential clinical role for FGFR3. While small numbers make this investigation somewhat exploratory, the findings merit future investigation on a larger scale. (C) 2013 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据